Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genotoxicity studies on ebrotidine

A Romero1, C Palacín, P Ciliutti

  • 1Centro de Investigación Farmacéutica Grupo Ferrer, Barcelona, Spain.

Arzneimittel-Forschung
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the WZ production cross section in pp collisions at [Formula: see text] and 8[Formula: see text] and search for anomalous triple gauge couplings at [Formula: see text].

The European physical journal. C, Particles and fields·2017
Same author

Suppression and azimuthal anisotropy of prompt and nonprompt [Formula: see text] production in PbPb collisions at [Formula: see text][Formula: see text].

The European physical journal. C, Particles and fields·2017
Same author

Improving risk assessment for post-surgical low cardiac output syndrome in patients without severely reduced ejection fraction undergoing open aortic valve replacement. The role of global longitudinal strain and right ventricular free wall strain.

The international journal of cardiovascular imaging·2017
Same author

Relative Modification of Prompt ψ(2S) and J/ψ Yields from pp to PbPb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2017
Same author

Pathology of Naturally Occurring Bacillary Hemoglobinuria in Cattle.

Veterinary pathology·2017
Same author

Measurement of the [Formula: see text] production cross section using events in the [Formula: see text] final state in pp collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2017

Ebrotidine was evaluated for genotoxicity using multiple assays, including bacterial gene mutations and chromosome aberration tests. The drug demonstrated no mutagenic or clastogenic effects in any tested system, indicating its safety.

Area of Science:

  • Pharmacology
  • Toxicology
  • Genetics

Background:

  • Ebrotidine (CAS 100981-43-9) is a novel drug candidate requiring comprehensive safety evaluation.
  • Genotoxicity testing is crucial for assessing potential risks associated with new pharmaceuticals.

Purpose of the Study:

  • To evaluate the genotoxic potential of ebrotidine.
  • To determine if ebrotidine causes gene mutations or chromosomal damage in vitro and in vivo.

Main Methods:

  • Conducted a battery of genotoxicity tests including Ames test, Drosophila sex-linked recessive lethal test, in vitro chromosome aberration test, micronucleus test, and sister chromatid exchange test.
  • Investigated effects with and without metabolic activation (S-9 fraction).
  • Performed a dose range toxicity study to establish appropriate test concentrations.

Related Experiment Videos

Main Results:

  • No significant increases in genotoxic parameters were observed across all conducted tests.
  • Ebrotidine did not induce bacterial gene mutations.
  • No evidence of mutagenic or clastogenic effects was found in eukaryotic systems (Drosophila, mammalian cells) or in vivo.

Conclusions:

  • Ebrotidine exhibits no mutagenic or clastogenic activity.
  • The results suggest a lack of genotoxic risk associated with ebrotidine.
  • Ebrotidine is considered safe from a genotoxicity perspective based on these findings.